Healthcare Resource Utilization for High-Risk Patients Treated with Dalbavancin in Physician Office Infusion Centers
Presented on November 26, 2018
Authors:
Quyen Luu, MD – Central Georgia Infectious Diseases Associates, Macon, GA
Barry Statner, MD, FRCPC, FIDSA – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
Robin H. Dretler, MD – Infectious Disease Specialists of Atlanta, P.C., Decatur, GA
H Barry Baker, MD, FACP – Infectious Disease Physicians, Miami, FL
Brian S. Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX
Thomas C Hardin, PharmD – Healix Infusion Therapy, Sugar Land, TX
Claudia P Schroeder, PharmD, PhD – Healix Infusion Therapy, Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc, Sugar Land, TX